Ruiying Chen

Ruiying Chen


Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 September 2018 in Clinical Hypertension
Verified
Journal Article
Open access
PDF file
SLShutan Liao
Shutan Liao
HWHao Wu
Hao Wu
RCRuiying Chen
Ruiying Chen
Preeclampsia (PE) is a serious maternal complication during pregnancy. Associated arterial stiffness in PE patients leads to increased risks of cardiovascular diseases later in life. Cholesterol efflux capacity, especially ATP binding cassette transporter A1 (ABCA1) dependent capacity, has been proposed to be a likely mediator of arterial stiffness. In the present study, we aimed to evaluate the effect of an apolipoprotein A1 mimetic peptide ATI-5261 on arterial stiffness in a mouse model of PE. Pregnant COMT−/− mice were randomized to receive vehicle or ATI-5261 (30 mg/kg per day) via subcutaneous injection from gestational days (GD) 10.5 to GD 18.5 or to 10 days postpartum. Pregnant C57BL/6 J mice received vehicle during paralleled periods were served as normal controls. COMT−/− mice displayed maternal hypertension and proteinuria during pregnancy. Carotid–femoral pulse wave velocity (PWV) was increased at GD 18.5 and 10 days postpartum. ATI-5261 treatment in COMT−/− mice significantly reduced PWV and partially normalized impaired ex vivo vascular function at late pregnancy and early postpartum. ATI-5261 treatment also increased serum ABCA1 concentrations and cholesterol efflux capacity, as well as ABCA1 expressions in the placenta. Pup weights, crown to rump lengths and abdominal circumferences were reduced in COMT−/− mice. Treatment with ATI-5261 did not alter these fetal measurements but significantly reduced placental weights and increased fetal to placental ratios in COMT−/− mice. ATI-5261 reversed arterial stiffness at late pregnancy and early postpartum in a COMT−/− mouse model of PE and may be a potential therapy for arterial stiffness associated with PE.

1 January 2019 in European Journal of Radiology
Verified
Journal Article
Closed access
KLKedan Liao
Kedan Liao
LTLian Tang
Lian Tang
CPCheng Peng
Cheng Peng
LCLan Chen
Lan Chen
RCRuiying Chen
Ruiying Chen
CCChunlin Chen
Chunlin Chen

31 May 2019 in Clinical Otolaryngology
Verified
Journal Article
Closed access
PDF file
SLShutan Liao
Shutan Liao
SLShan Lu
Shan Lu
GLGuangliang Li
Guangliang Li
RCRuiying Chen
Ruiying Chen

1 August 2023 in Journal of Cancer Research and Clinical Oncology
Verified
Journal Article
Open access
PDF file
XWXintao Wang
Xintao Wang
WSWenpei Shi
Wenpei Shi
XPXiaowen Pu
Xiaowen Pu
HYHu Yan
Hu Yan
RCRuiying Chen
Ruiying Chen
HZHaiyan Zhu
Haiyan Zhu
Purpose: Cervical adenocarcinoma is one of the most common types of cervical cancer and its incidence is increasing. The biological behavior and treatment outcomes of cervical adenocarcinoma (CA) differ from those of squamous cell carcinoma (SCC). We sought to develop a model to predict recurrence and cancer-specific survival (CSS) deaths in CA patients. Methods: 131 patients were included in model development and internal validation, and patients from the SEER database (N = 1679) were used for external validation. Multivariable Cox proportional hazards regression analysis was used to select predictors of relapse-free survival (RFS) and CSS and to construct the model, which was presented as two nomograms. Internal validation of the nomograms was performed using the bootstrap resampling method. Results: Age, FIGO (International Federation of Gynecology and Obstetrics) stage, size of the tumor, lymph metastasis and depth of invasion were identified as independent prognostic factors for RFS, while age, FIGO stage, size of the tumor and number of positive LNs were identified as independent prognostic factors for CSS. The nomogram of the recurrence model predicted 2- and 5-year RFS, with optimism adjusted c-statistic of 75.41% and 74.49%. Another nomogram predicted the 2- and 5-year CSS with an optimism-adjusted c-statistic of 83.22% and 83.31% after internal validation; and 68.6% and 71.33% after external validation. Conclusions: We developed and validated two effective nomograms based on static nomograms or online calculators that can help clinicians quantify the risk of relapse and death for patients with early-stage CA.